Eiko Lifesciences Ltd

₹ 49.2 -0.34%

10 Jul - close price

About

Incorporated in 2021, Eiko LifeSciences
Ltd manufacturing & sells Specialty
Chemical and Fine Chemicals^[1]

Key Points

Business Overview:^[1]
ELL is in the business of manufacturing, processing, formulating, producing, buying, selling, and exporting specialty and Fine Chemicals comprising organic & inorganic chemicals, and Pharma Intermediates, etc.

Website BSE

Market Cap ₹ 70.6 Cr.
Current Price ₹ 49.2
High / Low ₹ 64.4 / 45.9
Stock P/E 15.7
Book Value ₹ 47.9
Dividend Yield 0.00 %
ROCE 11.1 %
ROE 7.17 %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Company is almost debt free.
Stock is trading at 1.03 times its book value
Company is expected to give good quarter
Promoter holding has increased by 2.74% over last quarter.

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Promoter holding is low: 39.9%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	4.22	3.20	0.62	0.56	0.84	10.75	8.16	7.49	11.27	10.71	11.67	11.98	18.34
	6.10	4.55	1.53	0.42	0.89	10.35	7.73	6.86	9.95	9.20	9.90	10.10	16.08
Operating Profit	-1.88	-1.35	-0.91	0.14	-0.05	0.40	0.43	0.63	1.32	1.51	1.77	1.88	2.26
OPM %	-44.55%	-42.19%	-146.77%	25.00%	-5.95%	3.72%	5.27%	8.41%	11.71%	14.10%	15.17%	15.69%	12.32%
	0.05	0.01	-0.04	0.05	0.01	0.26	0.13	0.12	0.64	0.27	0.30	0.35	0.13
Interest	0.06	0.08	0.03	0.01	0.10	0.03	0.04	0.03	0.07	0.05	0.10	0.07	0.12
Depreciation	0.05	0.05	0.05	0.04	0.04	0.17	0.16	0.16	0.25	0.25	0.26	0.26	0.25
Profit before tax	-1.94	-1.47	-1.03	0.14	-0.18	0.46	0.36	0.56	1.64	1.48	1.71	1.90	2.02
Tax %	-25.77%	-25.85%	-28.16%	28.57%	-22.22%	26.09%	27.78%	25.00%	23.78%	25.00%	24.56%	24.74%	25.74%
	-1.42	-1.08	-0.74	0.10	-0.13	0.37	0.28	0.42	1.25	1.11	1.29	1.43	1.50
EPS in Rs	-1.11	-0.92	-0.64	0.09	-0.08	0.30	0.22	0.33	0.84	0.66	0.79	0.88	0.91
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2018	Mar 2019	Mar 2020	Mar 2025	Mar 2026
	2.36	4.27	10.40	37.66	52.71
	1.98	4.95	14.91	34.89	45.28
Operating Profit	0.38	-0.68	-4.51	2.77	7.43
OPM %	16.10%	-15.93%	-43.37%	7.36%	14.10%
	0.04	0.04	0.01	1.20	1.03
Interest	0.09	0.19	0.24	0.17	0.33
Depreciation	0.08	0.17	0.19	0.74	1.02
Profit before tax	0.25	-1.00	-4.93	3.06	7.11
Tax %	20.00%	-21.00%	-26.77%	24.51%	25.18%
	0.20	-0.78	-3.62	2.32	5.33
EPS in Rs	0.31	-0.69	-2.98	1.86	3.14
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	40%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	120%

Stock Price CAGR
10 Years:	%
5 Years:	-5%
3 Years:	-4%
1 Year:	-12%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	7%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2018	Mar 2019	Mar 2020	Mar 2025	Mar 2026
Equity Capital	3.82	3.82	3.82	13.76	14.35
Reserves	1.74	1.10	-0.87	43.03	54.43
	1.74	1.37	1.61	2.76	4.73
	3.66	3.01	7.49	6.56	15.86
Total Liabilities	10.96	9.30	12.05	66.11	89.37
	1.68	1.71	1.75	23.12	22.10
CWIP	0.00	0.00	0.00	0.00	0.00
Investments	3.17	1.72	0.10	7.15	15.29
	6.11	5.87	10.20	35.84	51.98
Total Assets	10.96	9.30	12.05	66.11	89.37

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2018	Mar 2019	Mar 2020	Mar 2025	Mar 2026
	0.00	0.16	-0.33	2.92	2.28
	0.00	-0.30	-0.71	-11.44	-8.66
	0.00	-0.55	0.95	6.96	8.21
Net Cash Flow	0.00	-0.69	-0.09	-1.57	1.83
Free Cash Flow	0.00	-0.04	-0.56	-7.37	2.28
CFO/OP	0%	-26%	7%	117%	50%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2018	Mar 2019	Mar 2020	Mar 2025	Mar 2026
Debtor Days	225.81	73.51	41.41	104.58	140.02
Inventory Days	819.93	287.76	153.96	64.48	35.09
Days Payable	605.69	174.40	184.66	36.99	111.03
Cash Conversion Cycle	440.04	186.87	10.72	132.07	64.08
Working Capital Days	80.42	-1.71	-151.62	143.73	127.55
ROCE %		-11.83%	-105.39%		11.08%

Insights

In beta

Mar 2021

Mar 2022

Mar 2023

Mar 2024

Mar 2025

Export Revenue Share
% ・Standalone data

xx.xx	x.xx	x.xx	x.xx	x.xx
x	x	x	x	x

Please log in to see hidden values.

Number of Permanent Employees
count ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
	23.73%	24.23%	24.23%	24.23%	24.40%	24.40%	31.27%	36.23%	36.74%	37.17%	37.17%	39.91%
	76.27%	75.77%	75.77%	75.76%	75.59%	75.59%	68.73%	63.78%	63.26%	62.81%	62.83%	60.09%
No. of Shareholders	2,155	2,722	2,637	2,913	2,938	3,140	3,456	3,336	3,322	3,150	3,092	2,969

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	5.96%	6.78%	6.78%	6.78%	21.37%	10.59%	23.73%	24.23%	36.23%	39.91%
	94.04%	93.22%	93.22%	93.22%	78.63%	89.41%	76.27%	75.76%	63.78%	60.09%
No. of Shareholders	528	219	240	219	298	537	1,874	2,913	3,336	2,969

Documents

Announcements

All

Annual reports

Concalls

May 2023

Transcript

AI Summary
PPT
Jul 2021

Transcript

AI Summary
PPT
Apr 2021

Transcript

AI Summary
PPT
Feb 2021

Transcript

AI Summary
PPT
Nov 2020

Transcript

AI Summary
PPT